CSIR Technology Portal
CSIR Technology Portal

 Technology Profile

Title:

Dry Powder Inhalation of Particles Containing Anti-tuberculosis Drugs

Value Proposition:

Dry powder Particles to completely irradicate tuberculosis (TB)-causing bacteria from the lungs.

Summary Application:
  • Treatment of pulmonary TB with orally-administered drugs is sub-optimal—exposing non-target tissues to toxic drugs and requiring large doses to build up effective concentrations in lungs
  • Prolonged dosing is required to build up and maintain effective concentrations in lungs
  • Patients remain infectious for considerable periods after initiating drug treatment.
Advantages:

It is safe and helps is reducing drug intake over time thereby reducing duration of treatment.

Tech. Readiness Level:
CSIR-Central Drug Research Institute
CSIR-Central Drug Research Institute[CSIR-CDRI]
:  director[at]cdri[dot]res[dot]in
:91-522-2772450
:https://www.cdri.res.in
Industrial Applications: Formulations [Drugs and Pharmaceuticals]
Patent(s): ZA200603256